Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies
- PMID: 31854449
- PMCID: PMC7327157
- DOI: 10.1093/ibd/izz203
Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies
Abstract
The prevalence of inflammatory bowel disease and costs of care are rising in the United States and highlight the need for effective, cost-effective therapies.
Keywords: Unites States; cost-effective therapies; database; inflammatory bowel disease; prevalence.
Comment on
-
Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.Inflamm Bowel Dis. 2020 Mar 4;26(4):619-625. doi: 10.1093/ibd/izz182. Inflamm Bowel Dis. 2020. PMID: 31504515
References
-
- Ye Y, Manne S, Treem WR, et al. . Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007–2016. Inflamm Bowel Dis. 2019; in press. - PubMed
-
- Dalhammer JM, Zammitti EP, Ward BW, et al. . Prevalence of inflammatory bowel disease among adults aged ≥ 18 years – United States, 2015. Morb Mortal Wkly Rep. 2016;65:1166–1169. - PubMed